Scan Me!
New users of sodium-glucose cotransporter 2 inhibitors may be more likely to undergo a lower extremity amputation when compared with users of other treatments for type 2 diabetes, such as sulfonylureas, metformin and thiazolidinediones, according to data published in JAMA Internal Medicine.”
Source: SGLT-2 inhibitors may increase risk for amputation in type 2 diabetes
New to Writers Site?
If so, you might be puzzled. The purpose of the Writers site is to provide dietitians in every niche with an opportunity to promote their independent businesses through Writing Articles within their specialty.
You Have Reached an Article Request Page: By publishing articles on NutriScape.NET, Dietitians can link to their own website or social media pages through the biography. We believe in Crowdsourcing. When RD/RDNs band together through The NutriScape Project, we can build a better future for all of us!
How to Use These Article Ideas
Labs
Supplements
Log in
Register
